open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:
Get Citation

The role of surgery in combinated treatment of cancers

M. Teresiak, J. Busza
DOI: 10.1016/S1428-2267(97)70149-2
·
Rep Pract Oncol Radiother 1997;2(2):60.

open access

Vol 2, No 2 (1997)
Untitled
Published online: 1997-01-01
Submitted:

Abstract

Surgery is the oldest and the most important treatment for cancer (75 – 80% patients presenting with cancer). Surgery is the simple, safe and the only treatment that could cure most patients (20% from 50% of 5 year survival).

Unfortunately, when patients with solid tumors present to the physician for the first time, about 50% already have micrometastases byeond the primary site.

The magnitude of surgical resection is modified by the use of adjuvant treatment modalities (radiotherapy, chemotherapy, biologic therapy – 50% of 5 year survival).

The role of surgery in the combinated treatment of cancer patients can be divided into a few separate areas:

  • *

    Definitive surgical treatment of primary cancer (operatio m. Halsted, m. Miles)

  • *

    Cytoreductive surgery (to reduce the bulk of residual disease)

  • *

    Surgical resection of metastatic disease (40% of 5 year survival in pulmonary and hepatic metastases)

  • *

    Surgery for palliation and oncologic emergencies (the treatment of exsanguinating hemorrhage, perforation, the relief of pain)

  • *

    Diagnostic surgery for exact histologic diagnosis and precise staging when planning

  • *

    Surgery in cancer prevention (carcinoma “in situ”, treatment to prevent subsequent cancers)

Slides show the role of surgery in combinated treatment of cancers.

Abstract

Surgery is the oldest and the most important treatment for cancer (75 – 80% patients presenting with cancer). Surgery is the simple, safe and the only treatment that could cure most patients (20% from 50% of 5 year survival).

Unfortunately, when patients with solid tumors present to the physician for the first time, about 50% already have micrometastases byeond the primary site.

The magnitude of surgical resection is modified by the use of adjuvant treatment modalities (radiotherapy, chemotherapy, biologic therapy – 50% of 5 year survival).

The role of surgery in the combinated treatment of cancer patients can be divided into a few separate areas:

  • *

    Definitive surgical treatment of primary cancer (operatio m. Halsted, m. Miles)

  • *

    Cytoreductive surgery (to reduce the bulk of residual disease)

  • *

    Surgical resection of metastatic disease (40% of 5 year survival in pulmonary and hepatic metastases)

  • *

    Surgery for palliation and oncologic emergencies (the treatment of exsanguinating hemorrhage, perforation, the relief of pain)

  • *

    Diagnostic surgery for exact histologic diagnosis and precise staging when planning

  • *

    Surgery in cancer prevention (carcinoma “in situ”, treatment to prevent subsequent cancers)

Slides show the role of surgery in combinated treatment of cancers.

Get Citation
About this article
Title

The role of surgery in combinated treatment of cancers

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 2, No 2 (1997)

Pages

60

Published online

1997-01-01

DOI

10.1016/S1428-2267(97)70149-2

Bibliographic record

Rep Pract Oncol Radiother 1997;2(2):60.

Authors

M. Teresiak
J. Busza

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl